• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物反应器中的两种差异流促进了人多能干细胞来源的巨核细胞中的血小板生成。

Two differential flows in a bioreactor promoted platelet generation from human pluripotent stem cell-derived megakaryocytes.

机构信息

Department of Micro-Nano Systems Engineering, Nagoya University, Aichi, Japan.

出版信息

Exp Hematol. 2013 Aug;41(8):742-8. doi: 10.1016/j.exphem.2013.04.007. Epub 2013 Apr 22.

DOI:10.1016/j.exphem.2013.04.007
PMID:23618622
Abstract

Induced pluripotent stem cell (iPSC) technology enables us to investigate various potential iPSC-based therapies. Although the safety of iPSC derivation has not been completely validated, anucleate cells, such as platelets or erythrocytes, derived from iPSCs are promising targets. However, the efficiency of in vitro platelet generation from megakaryocytes (MKs) under static culture conditions is lower than is seen in vivo. In this study, we demonstrate the proof of concept by a two-dimensional flow culture system that enabled us to increase platelet yield from human embryonic stem cell or iPSC-derived MKs using a biomimetic artificial blood vessel system. The bioreactor was composed of biodegradable scaffolds with ordered arrays of pores made to mimic in vivo bone marrow through salt leaching. Within the system, two flows in different directions in which the angle between the directions of flow is 60 degrees but not 90 degrees contributed to suitable pressure and shear stress applied to MKs to promote platelet generation. Generated platelets derived from human embryonic stem cells or human induced pluripotent stem cells through the bioreactor with a 60-degree angle revealed intact integrin αIIbβ3 activation after agonist stimulation. Collectively, our findings indicate that two flows in different directions of two-dimensional flow culture may be a feasible system for in vitro generation of platelets from pluripotent stem cells (i.e., iPSC-derived MKs) in numbers sufficient for transfusion therapy.

摘要

诱导多能干细胞(iPSC)技术使我们能够研究各种潜在的基于 iPSC 的治疗方法。尽管 iPSC 衍生的安全性尚未完全得到验证,但来自 iPSC 的无核细胞,如血小板或红细胞,是有前途的靶标。然而,在静态培养条件下,巨核细胞(MKs)体外生成血小板的效率低于体内。在这项研究中,我们通过二维流动培养系统证明了这一概念,该系统使用仿生人工血管系统,能够提高人胚胎干细胞或 iPSC 衍生的 MKs 来源的血小板产量。生物反应器由具有通过盐浸出模仿体内骨髓的有序孔阵列的可生物降解支架组成。在该系统中,两个方向相反的流,其流动方向之间的角度为 60 度而不是 90 度,有助于对 MKs 施加适当的压力和剪切应力,以促进血小板生成。通过生物反应器以 60 度角从人胚胎干细胞或人诱导多能干细胞生成的血小板在激动剂刺激后显示出完整的整合素αIIbβ3激活。总之,我们的研究结果表明,二维流动培养中两个方向的两个流可能是一种可行的系统,可用于从多能干细胞(即 iPSC 衍生的 MKs)体外生成足够用于输血治疗的血小板。

相似文献

1
Two differential flows in a bioreactor promoted platelet generation from human pluripotent stem cell-derived megakaryocytes.生物反应器中的两种差异流促进了人多能干细胞来源的巨核细胞中的血小板生成。
Exp Hematol. 2013 Aug;41(8):742-8. doi: 10.1016/j.exphem.2013.04.007. Epub 2013 Apr 22.
2
Structurally graduated collagen scaffolds applied to the ex vivo generation of platelets from human pluripotent stem cell-derived megakaryocytes: Enhancing production and purity.结构梯度胶原支架应用于从人多能干细胞来源的巨核细胞体外生成血小板:提高产量和纯度。
Biomaterials. 2018 Nov;182:135-144. doi: 10.1016/j.biomaterials.2018.08.019. Epub 2018 Aug 8.
3
Generation of Megakaryocytes and Platelets from Human Pluripotent Stem Cells.从人多能干细胞生成巨核细胞和血小板。
Methods Mol Biol. 2016;1307:371-8. doi: 10.1007/7651_2013_58.
4
In vitro generation of megakaryocytes and platelets from human embryonic stem cells and induced pluripotent stem cells.从人胚胎干细胞和诱导多能干细胞体外生成巨核细胞和血小板。
Methods Mol Biol. 2012;788:205-17. doi: 10.1007/978-1-61779-307-3_15.
5
Large-scale production of megakaryocytes in microcarrier-supported stirred suspension bioreactors.微载体支持的搅拌悬浮生物反应器中巨核细胞的大规模生产。
Sci Rep. 2018 Jul 5;8(1):10146. doi: 10.1038/s41598-018-28459-x.
6
Characterization and transplantation of induced megakaryocytes from hematopoietic stem cells for rapid platelet recovery by a two-step serum-free procedure.通过两步无血清程序从造血干细胞诱导生成巨核细胞的特性鉴定及移植以实现血小板的快速恢复
Exp Hematol. 2009 Nov;37(11):1330-1339.e5. doi: 10.1016/j.exphem.2009.07.012. Epub 2009 Aug 5.
7
Platelet bioreactor: accelerated evolution of design and manufacture.血小板生物反应器:设计与制造的加速演进
Platelets. 2017 Jul;28(5):472-477. doi: 10.1080/09537104.2016.1265922. Epub 2017 Jan 23.
8
Turbulence Activates Platelet Biogenesis to Enable Clinical Scale Ex Vivo Production.湍流激活血小板生成以实现临床规模的体外生产。
Cell. 2018 Jul 26;174(3):636-648.e18. doi: 10.1016/j.cell.2018.06.011. Epub 2018 Jul 12.
9
Generation and characterization of HLA-universal platelets derived from induced pluripotent stem cells.诱导多能干细胞来源的 HLA 通用性血小板的生成和鉴定。
Sci Rep. 2020 May 21;10(1):8472. doi: 10.1038/s41598-020-65577-x.
10
Platelet production from induced pluripotent stem cells.诱导多能干细胞生成血小板。
J Thromb Haemost. 2017 Sep;15(9):1717-1727. doi: 10.1111/jth.13736. Epub 2017 Jul 28.

引用本文的文献

1
Association of microtubule destabilization with platelet yields in terminally differentiating hiPSC-derived megakaryocyte lines.在终末分化的人诱导多能干细胞衍生的巨核细胞系中,微管去稳定化与血小板产量的关联。
PLoS One. 2025 Jun 25;20(6):e0326165. doi: 10.1371/journal.pone.0326165. eCollection 2025.
2
Cell-based artificial platelet production: historical milestones, emerging trends, and future directions.基于细胞的人工血小板生产:历史里程碑、新兴趋势及未来方向。
Blood Res. 2025 May 27;60(1):32. doi: 10.1007/s44313-025-00071-9.
3
Developing a Multichannel Bioreactor with a Collagen Scaffold, ECM, and Cryoprecipitate to Significantly Produce Platelets from Umbilical Cord Blood Stem Cells.
开发一种带有胶原蛋白支架、细胞外基质和冷沉淀的多通道生物反应器,以从脐带血干细胞中大量生产血小板。
Int J Hematol Oncol Stem Cell Res. 2023 Oct 1;17(4):245-256. doi: 10.18502/ijhoscr.v17i4.13916.
4
Ex vivo manufacturing of platelets: beyond the first-in-human clinical trial using autologous iPSC-platelets.离体制造血小板:超越使用自体 iPSC 血小板的首例人体临床试验。
Int J Hematol. 2023 Mar;117(3):349-355. doi: 10.1007/s12185-022-03512-8. Epub 2022 Dec 27.
5
Generation of HLA Universal Megakaryocytes and Platelets by Genetic Engineering.通过基因工程生成 HLA 通用巨核细胞和血小板。
Front Immunol. 2021 Oct 27;12:768458. doi: 10.3389/fimmu.2021.768458. eCollection 2021.
6
Human iPSC-derived macrophages for efficient Staphylococcus aureus clearance in a murine pulmonary infection model.人诱导多能干细胞衍生巨噬细胞可有效清除小鼠肺部感染模型中的金黄色葡萄球菌。
Blood Adv. 2021 Dec 14;5(23):5190-5201. doi: 10.1182/bloodadvances.2021004853.
7
Conditional CRISPR-mediated deletion of Lyn kinase enhances differentiation and function of iPSC-derived megakaryocytes.条件性 CRISPR 介导的 Lyn 激酶缺失增强了 iPSC 来源的巨核细胞的分化和功能。
J Thromb Haemost. 2022 Jan;20(1):182-195. doi: 10.1111/jth.15546. Epub 2021 Oct 17.
8
The Opportunities and Challenges regarding Induced Platelets from Human Pluripotent Stem Cells.人多能干细胞诱导血小板面临的机遇与挑战
Stem Cells Int. 2021 May 1;2021:5588165. doi: 10.1155/2021/5588165. eCollection 2021.
9
Development of platelet replacement therapy using human induced pluripotent stem cells.利用人诱导多能干细胞开发血小板替代疗法。
Dev Growth Differ. 2021 Feb;63(2):178-186. doi: 10.1111/dgd.12711. Epub 2021 Mar 4.
10
Generation and manipulation of human iPSC-derived platelets.人诱导多能干细胞来源血小板的生成与操控。
Cell Mol Life Sci. 2021 Apr;78(7):3385-3401. doi: 10.1007/s00018-020-03749-8. Epub 2021 Jan 13.